Effects of gamma-hydroxybutyric acid, baclofen, aminooxyacetic acid, and apomorphine on dopamine turnover in corpus striatum and limbic system.
D000085:Acetates / Q000494:pharmacology*; D000613:Aminobutyrates / Q000494:pharmacology*; D000625:Aminooxyacetic Acid / Q000494:pharmacology*; D000818:Animals; D001058:Apomorphine / Q000494:pharmacology*; D065105:Aromatic Amino Acid Decarboxylase Inhibitors; D001418:Baclofen / Q000494:pharmacology*; D003342:Corpus Striatum / Q000187:drug effects / Q000378:metabolism*; D004295:Dihydroxyphenylalanine / Q000096:biosynthesis; D004298:Dopamine / Q000378:metabolism*; D006834:Hydrazines / Q000494:pharmacology; D006885:Hydroxybutyrates / Q000494:pharmacology*; D008032:Limbic System / Q000187:drug effects / Q000378:metabolism*; D008781:Methyltyrosines / Q000494:pharmacology; D051381:Rats; D013378:Substantia Nigra / Q000378:metabolism; D014446:Tyrosine 3-Monooxygenase / Q000037:antagonists & inhibitors
D000085:Acetates; D000613:Aminobutyrates; D065105:Aromatic Amino Acid Decarboxylase Inhibitors; D006834:Hydrazines; D006885:Hydroxybutyrates; D008781:Methyltyrosines; D000625:Aminooxyacetic Acid; D004295:Dihydroxyphenylalanine; D014446:Tyrosine 3-Monooxygenase; D001418:Baclofen; D001058:Apomorphine; D004298:Dopamine